Sabra Healthcare REIT (NASDAQ:SBRA) Share Price Passes Above 200 Day Moving Average – Here’s What Happened

17 Apr 2026, 22:12 by Amy Steele · The Cerbat Gem

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $19.18 and traded as high as $20.57. Sabra Healthcare REIT shares last traded at $20.49, with a volume of 1,394,383 shares traded.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on SBRA shares. Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “overweight” rating in a report on Thursday, March 26th. Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Citigroup boosted their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, February 18th. UBS Group boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Thursday, February 19th. Finally, Truist Financial boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Friday, March 13th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $22.00.

View Our Latest Stock Report on SBRA

Sabra Healthcare REIT Trading Up 0.1%

The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $5.21 billion, a P/E ratio of 32.31, a PEG ratio of 1.65 and a beta of 0.67. The firm has a 50 day moving average of $20.17 and a 200-day moving average of $19.20.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last issued its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The company’s quarterly revenue was up 16.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. The ex-dividend date was Friday, February 13th. Sabra Healthcare REIT’s payout ratio is 187.50%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors have recently made changes to their positions in the stock. Cornerstone Wealth Management LLC boosted its stake in shares of Sabra Healthcare REIT by 256.6% in the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after buying an additional 28,625 shares during the period. AlphaQuest LLC lifted its stake in Sabra Healthcare REIT by 309.2% during the third quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock worth $2,700,000 after purchasing an additional 109,444 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al lifted its stake in Sabra Healthcare REIT by 51.2% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock worth $10,770,000 after purchasing an additional 195,600 shares during the last quarter. Allianz Asset Management GmbH lifted its stake in Sabra Healthcare REIT by 9.9% during the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock worth $16,832,000 after purchasing an additional 81,293 shares during the last quarter. Finally, Bank of Montreal Can lifted its stake in Sabra Healthcare REIT by 8.2% during the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock worth $51,962,000 after purchasing an additional 211,686 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.